FDA Inspection 1246288 — Marathwada Regional Cancer Center And Research Institute, GMCH
The FDA completed an inspection of Marathwada Regional Cancer Center And Research Institute, GMCH on May 24, 2024 in Aurangabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Aurangabad (India)
Additional Details
Clinical BA/BE